AbbVie
ABBV
#27
Rank
ยฃ296.33 B
Marketcap
ยฃ167.67
Share price
-0.06%
Change (1 day)
24.40%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) Fails to deliver data

Key failure to deliver metrics for AbbVie:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for AbbVie (ABBV) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for AbbVie (ABBV) - since 2013

Volume in USD (price x number of shares), data since 2013

AbbVie (ABBV) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ70.24 M-64.39%
2024ยฃ0.19 B-13.93%
2023ยฃ0.22 B-63.52%
2022ยฃ0.62 B629.28%
2021ยฃ86.13 M-77.97%
2020ยฃ0.39 B85.64%
2019ยฃ0.21 B-52.97%
2018ยฃ0.44 B269.88%
2017ยฃ0.12 B-48.45%
2016ยฃ0.23 B-37.53%
2015ยฃ0.37 B-44.13%
2014ยฃ0.67 B2387.79%
2013ยฃ27.05 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Pfizer
PFE
ยฃ24.63 Mยฃ0.10 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ6.09 Mยฃ0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ0.21 Bยฃ0.37 B๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ5.75 Mยฃ0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ60.15 Mยฃ0.26 B๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ22.86 Mยฃ94.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ72.01 Mยฃ0.40 B๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
ยฃ21.14 Mยฃ0.11 B๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ2.71 Mยฃ30.9 M๐Ÿ‡บ๐Ÿ‡ธ USA